The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular marker assessments for epidermal growth factor receptor (EGFR) expression by immunohistochemistry (IHC) and histoscore (H-score) in the phase III SELECT trial.
Edward S. Kim
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly
Sreenivas Chittoor
No relevant relationships to disclose
Craig H. Reynolds
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly
Lorinda Simms
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Scott Saxman
Employment or Leadership Position - Lilly
Stock Ownership - Lilly